Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.19.1
Accrued Expenses
 3 Months Ended
Mar. 31, 2019
Accrued Liabilities [Abstract]  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
4.
Accrued Expenses
 
Accrued expenses at March 31, 2019 and December 31, 2018 consist of the following: 
 
 
 
March 31,
2019
(unaudited)
 
 
December 31, 
2018
 
Payroll and Benefits
 
$
345,423
 
 
$
722,178
 
Professional Fees
 
 
112,284
 
 
 
165,894
 
Clinical Trials
 
 
111,631
 
 
 
212,540
 
Consulting
 
 
5,556
 
 
 
9,401
 
Short-Term Portion of Capital Financing Obligation
 
 
3,143
 
 
 
4,715
 
Total Accrued Expenses
 
$
578,037
 
 
$
1,114,728